Accenture Plc (ACN Stock) To Aquire Stagwell’s Concentric Life

• Accenture to acquire ConcentricLife, a unit of Stagwell, for $245 Million.
• The ACN stock price faced difficulty in sustaining the $330.00 mark.
• It is trading at 291.76 with a loss of 0.31% during the intraday session. 

Accenture to acquire Stagwell’s ConcentricLife healthcare marketing agency and pharmaceutical commercialization platform for $245 million in cash. The acquisition will bolster its existing healthcare marketing and communications capabilities for the life science industry. 

ConcentricLife, a unit of Stagwell, has over 270 employees. All of them will join the Accenture segment Accenture Song, according to the company. The buyers are eagerly waiting for the deal, which is likely to play a crucial role in the upcoming ACN stock growth story. 

The ACN stock price has been on a downtrend since September 2023, consistently attaining lower lows and melting from its initial high of $330.44. In May, Accenture’s stock price formed a strong support level at $261.68. It witnessed a sudden spike, which led to the formation of its yearly high at $330.44. 

However, during the course of six months, the stock price displayed a triple-top pattern, which indicates good selling opportunities for traders. However, the ACN stock price faced difficulty in attaining the $330 resistance level. Multiple attempts by buyers have gone in vain while contesting for the higher level. Each time, the price formed a strong resistance level near the $330 mark and dropped due to the heavy involvement of bears.

Currently, the ACN stock price is trading at $291.76 while witnessing a loss of 0.31% during the intraday session. Furthermore, the current market capitalization is 183.288 Billion, with an average trading volume of 1.792 Million. The year-to-date return reflects a positive growth of 8.48%, while the three-month return shows an opposing result of 8.66%.

Will the ACN Stock Price Retest The $285.20 Mark?

The Accenture (ACN) stock price is trading below the 20, 50, 100, and 200-day EMAs, indicating a rise in the participation of sellers in the market. Suppose the bullish sentiment prevails, the price might retest the short-term moving average. 

The Relative Strength Index (RSI) has been hovering below the 50-neutral zone since September 2023. It indicates the price has suffered tremendously from the prolonged downtrend. 

Moreover, the RSI is at 32.40, suggesting the price might fall into the oversold region if the bearish sentiment sustains. The Chaikin Money Flow (CMF) slid down from the 0 mark and strands at -0.12, suggesting intense weakness in the market. 

Conclusion 

The market structure and price action of Accenture stock price predominantly favors the sellers’ side, as the price has been stuck in a downtrend since September 2023. To challenge the bearish dominance, the company has to attract more bulls soon. 

However, Accenture is moving in the right direction with a plan to acquire Concentric Life for $245 Million. The acquisition will transform Accenture’s existing healthcare marketing and communications capabilities for the life science industry. 

Technical Levels

Major resistance: $327.93 and $330.44

Major support: $261.68 and $242.80

Disclaimer

The views and opinions stated by the author, or any people named in this article, are for informational purposes only. They do not establish financial, investment, or other advice. Investing in or trading crypto assets comes with a risk of financial loss.